In diffuse large B-cell lymphoma (DLBCL), KMT2D mutations promote the migration of Treg cells into the tumor microenvironment and suppress immune responses through the FBXW7-NOTCH-MYC/TGF-β1 signaling axis, thereby promoting tumor growth [29]. The gene discussed is KMT2D; the disease is neoplasm.